Carregant...
Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions
Several recent studies have shown that a single intravenous subanesthetic dose of ketamine, a NMDA receptor antagonist, exerts rapid antidepressant effects in patients with treatment refractory mood disorders and reduces suicidal ideation. Those insights have fueled tremendous excitement in the effo...
Guardat en:
| Publicat a: | CNS Neurosci Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493512/ https://ncbi.nlm.nih.gov/pubmed/23578128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12103 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|